These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3605188)

  • 1. Combined therapy of insulin and tolazamide decreases insulin requirement and serum triglycerides in obese patients with noninsulin-dependent diabetes mellitus.
    Kitabchi AE; Soria AG; Radparvar A; Lawson-Grant V
    Am J Med Sci; 1987 Jul; 294(1):10-4. PubMed ID: 3605188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.
    Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
    Diabetes Care; 1995 Aug; 18(8):1183-6. PubMed ID: 7587856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K; Cunningham GR; Comstock JP
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial.
    Firth R; Bell P; Marsh M; Rizza RA
    Diabetes; 1987 Oct; 36(10):1130-8. PubMed ID: 3308584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bed time NPH-insulin plus combined sulfonylurea-biguanide oral therapy for treating refractory non insulin dependent diabetic patients.
    di Cianni G; Benzi L; Ciccarone AM; Cecchetti P; Navalesi R
    Diabete Metab; 1992; 18(6):468-9. PubMed ID: 1297606
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus.
    Firth RG; Bell PM; Rizza RA
    N Engl J Med; 1986 May; 314(20):1280-6. PubMed ID: 3517644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
    Riddle MC; Hart JS; Bouma DJ; Phillipson BE; Youker G
    Diabetes Care; 1989 Oct; 12(9):623-9. PubMed ID: 2507265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glyburide or insulin for metabolic control in non-insulin-dependent diabetes mellitus. A randomized, double-blind study.
    Nathan DM; Roussell A; Godine JE
    Ann Intern Med; 1988 Mar; 108(3):334-40. PubMed ID: 3124685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea.
    Riddle M; Hart J; Bingham P; Garrison C; McDaniel P
    Am J Med Sci; 1992 Mar; 303(3):151-6. PubMed ID: 1595776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
    Low CC; Grossman EB; Gumbiner B
    Diabetes; 1996 May; 45(5):569-75. PubMed ID: 8621005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive use of tolazamide in newly-diagnosed diabetic children.
    Sanders R; Faro B; Stoler P; Mick GJ; McCormick KL
    Horm Metab Res; 1990 Nov; 22(11):576-80. PubMed ID: 2272604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short and Long Term Effects of a DPP-4 Inhibitor Versus Bedtime NPH Insulin as ADD-ON Therapy in Patients with Type 2 Diabetes.
    da Silva GM; Nogueira KC; Fukui RT; Correia MR; Dos Santos RF; da Silva ME
    Curr Pharm Des; 2016; 22(44):6716-6721. PubMed ID: 27928958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved metabolic control in insulin-dependent diabetes mellitus with insulin and tolazamide.
    Kabadi UM; Birkenholz MR
    Arch Intern Med; 1988 Aug; 148(8):1745-9. PubMed ID: 3041937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morning or bedtime NPH insulin combined with sulfonylurea in treatment of NIDDM.
    Groop LC; Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Schalin-Jäntti C; Eriksson JG
    Diabetes Care; 1992 Jul; 15(7):831-4. PubMed ID: 1516500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.